Nonsustained ventricular tachycardia: A guide to the clinical significance and management

Medical Clinics of North America

Volumn 85, Issue 2, 2001, Pages 305-320

  Weigner, Marilyn J ^b   Buxton, Alfred E ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENCAINIDE; FLECAINIDE; MORACIZINE; VERAPAMIL;

ALGORITHM; ANTICOAGULATION; ARRHYTHMOGENESIS; CATHETER ABLATION; CLINICAL EXAMINATION; CLINICAL TRIAL; DEFIBRILLATION; DISEASE CLASSIFICATION; DRUG EFFICACY; HEART DILATATION; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MITRAL VALVE PROLAPSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0035117175     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70317-5     Document Type: Article

References (74)

1. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction
2. Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction
3. Arrhythmia documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease
4. A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease
5. Repetitive, monomorphic ventricular tachycardia: Clinical and electrophysiologic characteristic in patients with and patients without organic heart disease
6. Prognostic factors in nonsustained ventricular tachycardia
7. Electrophysiologic studies in nonsustained ventricular tachycardia: Relationship to underlying heart disease
8. Right ventricular tachycardia: Clinical and electrophysiologic characteristics
9. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations
10. Prognostic implications of ventricular arrhythmias during 24-hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary disease
11. Repetitive monomorphic tachycardia from the left ventricular outflow tract: Electrocardiographic patterns consistent with a left ventricular site of origin
12. Ventricular arrhythmias in the first 12 hours of acute myocardial infarction
13. Preliminary report: Effect on encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
14. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
15. Limitations of 24 hour ambulatory electrocardiography recording in predicting coronary events after acute myocardial infarction
16. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: Tachycardia characteristics and their prognostic significance
17. Ventricular premature deaths and anatomically defined coronary heart disease
18. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias
19. Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24 hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial
20. The relationship of paroxysmal ventricular tachycardia complicating the acute phase and ventricular arrhythmia during the late hospital phase of acute infarction to long-term survival
21. Nonsustained ventricular tachycardia in severe heart failure: Independent marker of increased motality due to sudden death
22. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: A prospective study
23. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone
24. Prevalence and clinical outcome of mitral-valve prolapse
25. Programmed electrical stimulation in patients with high grade ectopy: Electrophysiologic findings and prognosis for survival
26. Predictors of total mortality and sudden cardiac death in mild to moderate heart failure
27. The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men
28. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography
29. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients
30. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction
31. Findings on ambulatory electrocardiographic monitoring in subjects older than 80 years
32. Frequent or complex ventricular ectopy in apparently healthy subjects
33. Effect of direct, reflex and exerciseprovoked increase in sympathetic tone on idiopathic ventricular tachycardia
34. Relationship between clinical features of acute myocardial infarction and ventricular runs 2 weeks to 1 year after myocardial infarction
35. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease
36. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: Prognostic and therapeutic implications
37. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: Contrast to arrhythmias in mitral valve prolapse without mitral regurgitation
38. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse
39. Reconsideration of echocardiographic standards for mitral valve prolapse: Lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality
40. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2
41. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
42. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
43. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in patients with hypertrophic cardiomypathy
44. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk
45. Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy
46. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed stimulation
47. Programmed ventricular stimulation in mitral valve prolapse: Analysis of 36 patients
48. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
49. Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment
50. Arrhythmias in dilated cardiomyopathy
51. Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: An angiographic study
52. Echocardiographically documented mitral valve prolapse: Long term follow up of 237 patients
53. Long term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy
54. Sudden death in primary mitral valve prolapse
55. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy
56. Defibrillators in nonischemic cardiomyopathy treatment eval
57. Nonsustained ventricular tachycardia arising from the right ventricular outflow tract
58. Arrhythmias on ambulatory electrocardiographic monitoring in women without apparent heart disease
59. Myocardial infarction patients in the 1990's - Their risk factors, stratification and survival in Canada
60. Prevalence of arrhythmia during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive cardiomyopathy
61. Sudden death in the year following myocardial infarction: Relation to ventricular premature contractions in the late hospital phase and left ventricular ejection fraction
62. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy
63. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia
64. The management of hypertrophic cardiomyopathy
65. The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation
66. Prevalence of ventricular tachycardia in patients with different underlying heart disease: A study by holter ECG monitoring
67. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death
68. Determinants of ventricular arrhythmias in mildly symptomatic patients with coronary artery disease and the influence of inducible left ventricular dysfunction and arrhythmia frequency
69. Factors influencing the one year mortality of dilated cardiomyopathy
70. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge
71. Frequency and significance of cardiac rhythm disturbances in healthy elderly individuals
72. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death
73. Electrophysiologic testing and nonsustained ventricular tachycardia: Use and limitations in patients with coronary artery disease and impaired ventricular function
74. Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity